...
首页> 外文期刊>RSC Advances >Development of a radiopaque, long-term drug eluting bioresorbable stent for the femoral-iliac artery
【24h】

Development of a radiopaque, long-term drug eluting bioresorbable stent for the femoral-iliac artery

机译:股骨artery动脉不透射线的长期药物洗脱生物可吸收支架的开发

获取原文
           

摘要

Tubular tissues exist in various forms purported for blood supply, waste secretion, etc. to aid proper function and maintenance of the human body. Under pathological conditions, however, these tissues may undergo stenosis. A major surgical treatment for stenosis is to implant a medical device called a stent which aims to expand the narrowed tissue and maintain its patency. Most stents are currently made from metals; despite their high mechanical strength, however, interactions with the host tissue often results in restenosis and stent fracture. To solve these problems, a bioresorbable stent (BRS) is proposed as a next generation stent. In this study, a rotating rod combined 3D printing system was developed to fabricate various types of BRSs. In addition, we confirmed that a 1.5 year long-term release of paclitaxel is possible using polymeric materials. Moreover, a stent loaded with contrast powder was fabricated and was successfully viewed under fluoroscopy. The stent was then implanted in the iliac arteries of pigs and no adverse events were observed for up to 8 weeks.
机译:管状组织以各种形式存在,据称可用于血液供应,废物分泌等,有助于人体的正常功能和维护。但是,在病理条件下,这些组织可能会狭窄。狭窄的主要外科治疗方法是植入称为支架的医疗器械,该器械旨在扩大狭窄的组织并保持其通畅。目前大多数支架是由金属制成的。尽管它们具有很高的机械强度,但与宿主组织的相互作用通常会导致再狭窄和支架断裂。为了解决这些问题,提出了生物可吸收支架(BRS)作为下一代支架。在这项研究中,开发了旋转杆组合3D打印系统以制造各种类型的BRS。此外,我们确认使用聚合物材料可以使紫杉醇1.5年长期释放。而且,制造了装有造影剂粉末的支架,并在荧光检查下成功地对其进行了观察。然后将支架植入猪的art动脉,长达8周未观察到不良事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号